What is the significance of a Wilkins score of 2 on transthoracic echocardiography and what management is recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Wilkins Score of 2: Excellent Prognosis for Percutaneous Intervention

A Wilkins score of 2 indicates highly favorable mitral valve morphology with minimal leaflet thickening, subvalvular disease, calcification, and excellent mobility—this patient is an ideal candidate for percutaneous mitral balloon commissurotomy (PMBC) if they have severe mitral stenosis (MVA ≤1.5 cm²). 1

Understanding the Wilkins Score

The Wilkins score assesses four echocardiographic parameters (leaflet mobility, thickening, calcification, and subvalvular apparatus involvement), each scored 1-4, with total scores ranging from 4-16. A score of 2 suggests only one parameter is mildly abnormal while others are normal, or all parameters are nearly normal—representing optimal valve anatomy for intervention.

Clinical Significance and Management Algorithm

If Patient is Symptomatic with Severe MS (MVA ≤1.5 cm²):

  • PMBC is the Class I recommendation with Level of Evidence A 1
  • The procedure should be performed by experienced operators with immediate surgical backup
  • Contraindications must be excluded: left atrial thrombus (requires TEE) and moderate-to-severe mitral regurgitation 1
  • Expected outcomes are excellent given the favorable morphology—studies show optimal results (≥25% increase in MVA to >1.5 cm²) in patients with low Wilkins scores 1

If Patient is Asymptomatic:

Consider PMBC if:

  • Very severe MS (MVA ≤1.0 cm²) - Class IIa recommendation 1
  • New-onset atrial fibrillation - Class IIb recommendation, as lowering left atrial pressure may facilitate rhythm control 1
  • Pulmonary artery systolic pressure >50 mmHg 2

If MVA >1.5 cm²:

  • PMBC may be considered only if exercise testing demonstrates hemodynamically significant MS (pulmonary wedge pressure >25 mmHg or mean gradient >15 mmHg during exercise) - Class IIb 1

Key Prognostic Points

The Wilkins score of 2 predicts:

  • High procedural success rate for PMBC 1
  • Low risk of significant mitral regurgitation post-procedure 3
  • Better long-term event-free survival compared to higher scores 4

While newer scoring systems incorporating commissural morphology and leaflet displacement may provide additional predictive value 4, the traditional Wilkins score remains the guideline-endorsed standard for patient selection 1, 2. A score of 2 places this patient in the most favorable category regardless of which scoring system is used.

Common Pitfalls to Avoid

  • Do not delay intervention in symptomatic patients with favorable anatomy waiting for "more severe" disease—PMBC is indicated at MVA ≤1.5 cm² with symptoms 1
  • Always obtain TEE before PMBC to exclude left atrial thrombus, even with favorable transthoracic findings 2
  • Assess for moderate-to-severe MR carefully—this is an absolute contraindication to PMBC regardless of favorable Wilkins score 1
  • Recent evidence suggests the traditional cutoff of Wilkins score ≤8 for PMBC candidacy may be too restrictive 5, but with a score of 2, this patient is unequivocally suitable

Surgical Consideration

Mitral valve surgery would only be indicated if PMBC fails, contraindications exist, or if the patient requires other cardiac surgery (in which case concomitant mitral intervention is Class I) 1. With a Wilkins score of 2, surgery should not be the first-line approach.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.